Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Multiple Myeloma (NDMM)

Explore clinical trials studying Newly Diagnosed Multiple Myeloma (NDMM). Study availability and eligibility vary by location and protocol.

8 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Newly Diagnosed Multiple Myeloma (NDMM) trial results

Recruiting

Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients

NCT07087964

Conditions
Newly Diagnosed Multiple Myeloma (NDMM)
Locations
  • Universitair ziekenhuis Antwerpen Antwerp, Antwerpen, Belgium
  • Universitair ziekenhuis Gent Ghent, Oost Vlaandere, Belgium
  • Universitair Ziekenhuis Leuven Leuven, Vlaams-Brabant, Belgium
  • AZ Sint-Jan Brugge Bruges, West-Vlaandere, Belgium
View Trial Details
Not Yet Recruiting

A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

NCT07735637

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 65 locations
View Trial Details
Not Yet Recruiting

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

NCT07247097

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions